MedPath

Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.

Not Applicable
Recruiting
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000012422
Lead Sponsor
Kansai Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with known hypersensitivity to Erythropoiesis-stimulating agents (Epoetin alfa,Epoetin beta, Darbepoetin alfa,Epoetin beta pegol) 2. Patients under 20 years old. 3. Patients judged inappropriate by attending physicians.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Volume of blood salvage by renal function. 2.Maintenance of perioperative period hemoglobin
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath